Counterpoint Mutual Funds’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,838
Closed -$94.6K 401
2023
Q1
$94.6K Buy
+1,838
New +$89.2K 0.08% 285

Other funds holding LMAT

Counterpoint Mutual Funds's LMAT Position: Q2 2023 in Review

Counterpoint Mutual Funds sold out of LeMaitre Vascular (LMAT) in Q2 2023, closing a stake of 1,838 shares — an estimated $94.6K sold.

Counterpoint Mutual Funds first reported a position in LMAT in Q1 2023 and held it in 1 quarter. The position peaked at $94.6K in Q1 2023. 212 funds tracked by Wall St. Rank hold LMAT as of Q2 2023.

  • Counterpoint Mutual Funds reported no remaining LeMaitre Vascular position as of Q2 2023 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 1,838 LeMaitre Vascular shares in Q2 2023, an estimated $94.6K.
  • Counterpoint Mutual Funds first reported a position in LeMaitre Vascular in Q1 2023 and held it in 1 quarter.
  • Counterpoint Mutual Funds's LeMaitre Vascular position peaked at $94.6K in Q1 2023.
  • 212 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2023.

Based on Counterpoint Mutual Funds's 13F filing for Q2 2023, filed 13 Jul 2023.